HSCS

HeartSciences Inc.
—

Company Information

Company Name
HeartSciences Inc.
CIK
CIK0001468492
Category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ticker: Exchange
HSCS: Nasdaq, HSCSW: Nasdaq
Fiscal Year End
April 30
Owner Organization
09 Crypto Assets
SIC
6199
SIC Description
Finance Services
Ticker
HSCS

SEC filing data through

Insider Sentiment

Last purchase
—
Last sale
2025-07-29
Shares purchased (TTM)
0
Shares sold (TTM)
4,416
Buy ratio (TTM)0.0%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
153,699
Shares outstanding
3,668,945
Ownership
4.19%
-0.44% Y/Y

Earnings Market Reaction

Filing date
2026-09-14
Price on filing date
—
1-month reaction
…
3-month reaction
…
Drift continued3/8 (38%)
Faded / reversed5/8 (63%)

Balance Sheet

Values in millions ($)
Line item2026-07-312026-04-302026-01-312025-10-312025-07-312025-04-302025-01-312024-10-312024-07-312024-04-302024-01-312023-10-31Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Series A B C Convertible Preferred Stock-----0000000
Assets
Accounts Receivable Net Current--0--0----00
Cash And Cash Equivalents At Carrying Value023231344670
Assets Current
Inventory Net011111111111
Prepaid Expense Current0-0000000000
Deferred Offering Costs001110011111
Other Assets Current0-0000000000
Assets Current1-5442466792
Property Plant And Equipment Net000000000000
Capitalized Computer Software Net1100--------
Finite Lived Intangible Assets Net---22222222-
Intangible Assets Net Excluding Goodwill--2---------
Operating Lease Right Of Use Asset000000000001
Assets4-866468810112
Liabilities And Stockholders Equity
Accounts Payable Current1-0000000001
Accrued Liabilities Current---011000011
Interest Payable Current0-000000-0--
Operating Lease Liability Current000000000000
Notes Payable Current443123320111
Other Liabilities Current0-0000000000
Liabilities Current6-4234431224
Liabilities Noncurrent
Long Term Notes Payable0-0----010--
Accounts Payable And Accrued Liabilities Noncurrent-------0-0--
Operating Lease Liability Noncurrent000000000000
Liabilities Noncurrent0-1000001000
Liabilities6-5234442224
Stockholders Equity
Common Stock Value0-0000000000
Additional Paid In Capital86-85858176767675757462
Retained Earnings Accumulated Deficit-88-85-83-81-78-76-74-71-69-67-66-64
Stockholders Equity-20343024679-2
Liabilities And Stockholders Equity4-866468810112
Series C Convertible Preferred Stock---00--00---
Series D Convertible Preferred Stock---00-0-----
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Preferred Stock Shares Authorized202020202020202020202020
Preferred Stock Shares Issued-----0---0--
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.000.00
Common Stock Shares Authorized500500500500500500500500500500500500
Common Stock Shares Issued433321111110
Shares Outstanding4-3321111110

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

HeartSciences Inc. (HSCS) — SEC Financial Statements & Analysis

HeartSciences Inc. (HSCS) is a finance services company, incorporated in TX. HeartSciences Inc. trades on Nasdaq as: HSCS, HSCSW. HeartSciences Inc. (HSCS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-07-31, filed with the SEC on 2026-09-14. Based on that filing, HeartSciences Inc. carries a market cap of $8.00M, a P/E ratio of -0.78x, a P/B ratio of -3.93x, a P/S ratio of 1769.93x, an enterprise value of $11.69M, and an EV/EBITDA multiple of -1.24x. On profitability, it posts an operating margin of -209733.08%, a net margin of -227024.23%, a Return on Equity (ROE) of -1851.90%, a Return on Assets (ROA) of -201.67%, and a Return on Invested Capital (ROIC) of -533.95%. Per share, it reports EPS of $-2.80, diluted EPS of $-3.25, free cash flow per share of $-1.86, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -27.70% year-over-year, net income growth of 17.00% year-over-year, and EPS growth of -58.43% year-over-year. On the balance sheet, it maintains a current ratio of 0.14x, a quick ratio of 0.03x, working capital of $-4.82M, a debt-to-equity ratio of -2.84x, a debt ratio of 1.54, an interest coverage ratio of -11.78x, free cash flow of $-6.82M (TTM), and net debt of $3.69M. Figures sourced from SEC EDGAR.

Market Cap
$8.00M
P/E TTM
-0.78x
EPS TTM
$-2.80
P/B TTM
-3.93x
ROE TTM
-1851.90%
ROA TTM
-201.67%
Debt To Equity
-2.84x
Free Cash Flow TTM
$-6.82M
Net Revenue TTM Growth 1Y
-27.70%

Data as of 2026-07-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is HeartSciences Inc. in?

HeartSciences Inc. (HSCS) operates in the Finance Services industry.

What exchange does HSCS trade on?

HeartSciences Inc. (HSCS) trades on the Nasdaq.

Where is HeartSciences Inc. incorporated?

HeartSciences Inc. is incorporated in TX.

When was HeartSciences Inc. (HSCS)'s most recent SEC filing?

HeartSciences Inc. (HSCS)'s most recent SEC filing is a Form 10-Q for the period ended 2026-07-31, filed with the SEC on 2026-09-14.

What is HSCS's market cap?

HeartSciences Inc. (HSCS) has a market capitalization of $8.00M as of 2026-07-31.

What is HSCS's EPS (earnings per share)?

HeartSciences Inc. (HSCS)'s trailing twelve month EPS is $-2.80 as of 2026-07-31.

What is HSCS's ROE (return on equity)?

HeartSciences Inc. (HSCS)'s trailing twelve month Return on Equity (ROE) is -1851.90% as of 2026-07-31.

What is HSCS's ROA (return on assets)?

HeartSciences Inc. (HSCS)'s trailing twelve month Return on Assets (ROA) is -201.67% as of 2026-07-31.

What is HSCS's ROIC (return on invested capital)?

HeartSciences Inc. (HSCS)'s trailing twelve month Return on Invested Capital (ROIC) is -533.95% as of 2026-07-31.

What is HSCS's EV/EBITDA?

HeartSciences Inc. (HSCS)'s trailing twelve month EV/EBITDA is -1.24x as of 2026-07-31.

Wall Street's data.
Main Street's price.